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a b s t r a c t
Mutations in the human ether-a-go-go-related gene (hERG) result in long QT syndrome type 2 (LQT2). The hERG
gene encodes a K+ channel that contributes to the repolarization of the cardiac action potential. We have previously shown that hERG mRNA transcripts that contain premature termination codon mutations are rapidly degraded by nonsense-mediated mRNA decay (NMD). In this study, we identiﬁed a LQT2 nonsense mutation,
Q81X, which escapes degradation by the reinitiation of translation and generates N-terminally truncated channels. RNA analysis of hERG minigenes revealed equivalent levels of wild-type and Q81X mRNA while the mRNA
expressed from minigenes containing the LQT2 frameshift mutation, P141fs+2X, was signiﬁcantly reduced by
NMD. Western blot analysis revealed that Q81X minigenes expressed truncated channels. Q81X channels
exhibited decreased tail current levels and increased deactivation kinetics compared to wild-type channels.
These results are consistent with the disruption of the N-terminus, which is known to regulate hERG deactivation. Site-speciﬁc mutagenesis studies showed that translation of the Q81X transcript is reinitiated at Met124 following premature termination. Q81X co-assembled with hERG to form heteromeric channels that exhibited
increased deactivation rates compared to wild-type channels. Mutant channels also generated less outward current and transferred less charge at late phases of repolarization during ventricular action potential clamp. These
results provide new mechanistic insight into the prolongation of the QT interval in LQT2 patients. Our ﬁndings
indicate that the reinitiation of translation may be an important pathogenic mechanism in patients with nonsense and frameshift LQT2 mutations near the 5′ end of the hERG gene.
© 2012 Elsevier Ltd. All rights reserved.

1. Introduction
The human ether-a-go-go-related gene (hERG) encodes the poreforming subunit of a voltage-gated K+ channel, a component of the
rapidly-activating delayed rectiﬁer current (IKr) in the heart [1,2]. hERG
channels exhibit unique voltage-dependent properties including rapid
inactivation and slow deactivation. Mutations in hERG cause the congenital form of long QT syndrome type 2 (LQT2), an inherited autosomal
dominant disorder characterized by prolonged QT interval on the electrocardiogram. Patients with LQT2 are susceptible to severe ventricular
arrhythmias that can lead to sudden death [3,4]. Approximately
one-third of identiﬁed LQT2 mutations are nonsense, frameshift and
splice site mutations that introduce premature termination codons
(PTCs) into the coding sequence of hERG [5–9]. We have previously
shown that hERG mRNA transcripts that contain PTC mutations are
degraded by nonsense-mediated mRNA decay (NMD) [10,11]. NMD is
an evolutionarily conserved RNA surveillance mechanism that recognizes
and eliminates PTC-containing transcripts [12,13]. The degradation of
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hERG transcripts containing PTC mutations by NMD has been shown to
prevent the formation of truncated channel proteins that would otherwise exert a dominant-negative effect on wild-type hERG current
[10,14]. NMD may also increase the pathogenicity of LQT2 by preventing
the formation of truncated channels that retain functionality [15,16].
In mammalian cells, PTCs are distinguished by their physical location relative to the 3′ most exon–exon junction. As opposed to naturally
occurring stop codons that usually occur in the terminal exon, nonsense
codons located >50 to 55 nt upstream of the 3′-most exon–exon junction target the transcript for degradation by NMD [17]. Several studies,
however, have identiﬁed PTC mutations near the translation start site
that resist NMD when post-termination ribosomes resume scanning
and reinitiate translation at downstream methionine codons [18–20].
Several nonsense and frameshift LQT2 mutations have been identiﬁed early in the coding sequence of hERG [5–9]. We studied two of
these mutations ﬁrst reported by Splawski et al., Q81X and P141fs+2X
[5]. We report that Q81X transcripts escaped NMD by the reinitiation
of translation and generated N-terminally truncated channels that
exhibited decreased tail current levels and accelerated deactivation
rates. Q81X also generated less outward current and transferred less
charge during the late phases of action potential repolarization. The
reinitiation of translation represents a new mechanism of hERG channel
dysfunction in LQT2.

2. Materials and methods
2.1. hERG minigene and cDNA constructs
The construction of the full-length hERG minigene composed of
cDNA from exons 1–10 and genomic DNA from intron 10 to the
polyadenylation site has been previously described [16]. The Q81X and
P141fs+2X mutations were generated by site-directed mutagenesis
using the pAlter in vitro mutagenesis system (Promega, Madison, WI).
Wild-type and mutant hERG minigenes and cDNA constructs were
subcloned into pcDNA3.1/Hygro (+) expression vectors (Invitrogen,
Carlsbad, CA). The Flag and hemagglutinin (HA) epitopes were inserted
in frame at the C-terminus of the wild-type and Q81X cDNA constructs.
For western blot and immunoprecipitation experiments human embryonic kidney (HEK)293 cells were seeded on 60 mm culture plates and
transiently transfected with 1 μg of the hERG minigene or cDNA constructs using the Effectene method (Qiagen, Valencia, CA). For patch
clamp studies HEK293 cells were seeded on 35 mm culture plates and
transiently transfected with 0.4 μg of the hERG minigene constructs
and 0.1 μg of green ﬂuorescent protein cDNA to serve as an indicator.
Wild-type and mutant constructs were co-transfected at equimolar
concentrations to study the functional properties of heteromeric
channels. In immunoprecipitation studies, a HEK293 cell line stably
expressing Flag-tagged wild-type hERG was transiently transfected
with HA-tagged wild-type or Q81X cDNA constructs. HEK293 cells
were cultured in DMEM supplemented with 10% fetal bovine serum.
HL-1 murine cardiomyocytes [21] were transiently transfected with
wild-type and Q81X HA-tagged constructs using Lipofectamine 2000
(Invitrogen). HL-1 cells were cultured in Claycomb medium (SigmaAldrich, St. Louis, MO) supplemented with 10% fetal bovine serum and
0.1 mM norepinephrine (Sigma-Aldrich).
2.2. RNase protection assay
The level of mRNA was analyzed by the RNase protection assay with
a probe spanning 277 nt of exons 12 and 13 as described [16]. The total
length of the probe was 409 nt and contained sequences from the pCRII
vector at both ends. Yeast RNA was used as a control for the complete
digestion of the probes by RNase. The expression level of the
hygromycin B resistance gene from the pcDNA3.1/Hygro vector was
used as a loading control. The relative intensity of each band was quantiﬁed using ImageJ [22].
2.3. Western blot and immunoprecipitation
Western blot analysis and immunoprecipitation were performed as
previously described [23,24]. Flag-tagged and HA-tagged hERG channels from whole cell lysates were subjected to SDS-PAGE, transferred
onto nitrocellulose membranes, detected with the anti-HA, anti-Flag
or the anti-hERG C-terminus antibody, and visualized with the PlusECL (PerkinElmer, Waltham, MA) detection kit. In the immunoprecipitation experiments, hERG channels were immunoprecipitated with
anti-Flag antibody and detected by western blot with the anti-HA and
the anti-Flag antibody.
2.4. Patch clamp recordings
Membrane currents were recorded in whole cell conﬁguration using
an Axopatch-200B patch clamp ampliﬁer. pCLAMP8 software (Molecular Devices, Sunnyvale, CA) was used for data acquisition and analysis of
current signals. The action potential clamp was performed using a
human ventricular action potential waveform with a sampling rate of
1.04 kHz. Cells were superfused with HEPES-buffered Tyrode solution
containing 137 mM NaCl, 4 mM KCl, 1.8 mM CaCl2, 1 mM MgCl2,
10 mM glucose, and 10 mM HEPES (pH 7.4). The pipette solution
contained 130 mM KCl, 1 mM MgCl2, 5 mM EGTA, 5 mM MgATP, and

10 mM HEPES (pH 7.2). All patch clamp experiments were performed
at room temperature except for action potential clamp experiments
that were carried out at 35± 1 °C.
The corrected peak tail current was determined by ﬁtting the deactivation phase with double exponential function and extrapolating to
the beginning of the pulse [25]. Current density was obtained by normalizing hERG current to cell capacitance and is expressed as pA/pF.
The charge transferred during the action potential clamp was obtained
by integrating the area under the current trace. Charge density was
obtained by normalizing charge to cell capacitance and is expressed as
pC/pF. The voltage-dependence of inactivation was calculated using a
three-step protocol as previously described [26–28]. The peak current
amplitudes at potentials between −100 and −120 mV were corrected
for errors due to deactivation using the following equation as previously
described [28]: Icorrected = [(Ipeak − Iend) / (Emem − Erev)] × (40 − Erev),
where Ipeak is the peak current during the hyperpolarizing step, Iend is
the current level at the end of the hyperpolarizing step, Emem is the
test potential, and Erev is the reversal potential. The data were ﬁt using
a Boltzmann function. Data analysis was performed using SigmaPlot
(San Jose, CA) and are presented as mean± standard error of the
mean (SEM). Statistical comparisons were performed using Student's
t-test and ANOVA as appropriate. The Holm–Sidak method was used
in ANOVA to identify signiﬁcant differences between means. Values of
P b 0.05 were considered statistically signiﬁcant.
3. Results
3.1. hERG transcripts containing the Q81X mutation are resistant to NMD
To test whether PTC mutations occurring early in the coding sequence of hERG were susceptible to NMD we analyzed the mRNA
expressed from minigenes containing Q81X or the P141fs+2X LQT2
mutations (Fig. 1). A schematic of the hERG minigene composed of
cDNA from exon 1 to exon 10 and genomic DNA from intron 10 to the
polyadenylation signal is shown in Fig. 1A. HEK293 cells were transiently transfected with wild-type, Q81X or P141fs+2X minigenes and the
presence of mRNA was determined by the RNase protection assay
using a probe that hybridized to 277 nt of exons 12 and 13 of the spliced
minigene. As shown in Fig. 1B, a similar level of wild-type and Q81X
mRNA was detected, while P141fs+2X mRNA levels were signiﬁcantly
reduced compared to wild-type (P b 0.05, ANOVA). The quantitative
analysis of the normalized signals revealed that P141fs+2X mRNA
was 15± 3% of wild-type (n= 4) (Fig. 1C). Because NMD is dependent
on protein translation we performed the assay in the presence of the
protein synthesis inhibitor cycloheximide. Cycloheximide has been
shown to abrogate NMD in PTC-containing transcripts [10,29]. Treatment with cycloheximide restored the expression of P141fs+2X
mRNA to levels comparable to wild-type and Q81X levels but had no
effect on the expression of the wild-type and Q81X transcripts. These
results suggest that the Q81X mutation, but not the P141fs+2X mutation, is resistant to NMD.
3.2. Q81X channels are expressed as truncated proteins
To determine whether Q81X transcripts were translated into hERG
channel proteins we performed western blot analysis of the proteins
expressed from the mutant minigenes. HEK293 cells were transiently
transfected with wild-type, Q81X or P141fs+2X minigenes and the
channel proteins were detected using a polyclonal antibody directed
against the hERG C-terminus. As shown in Fig. 2A, wild-type channels
were expressed as a 135 kDa, core-glycosylated form of the channel
that is associated with the endoplasmic reticulum and a 155 kDa,
complex-glycosylated channel that is expressed at the cell surface [23].
Q81X channel proteins were expressed at 120 kDa and 140 kDa,
suggesting that the core- and complex-glycosylated forms of the mutant
channel were truncated compared to wild-type hERG. In contrast to

wild-type and Q81X, we did not detect hERG channels in cells
transfected with the P141fs+2X minigene. To determine whether
Q81X channels could be expressed in heart cells we transiently
transfected the HL-1 murine cardiomyocyte cell line with the wild-type
and mutant constructs and analyzed protein expression by western
blot (Fig. 2B). A similar expression pattern was observed for the wildtype and Q81X channels indicating that cardiac myocytes were also
able to generate the mutant channel proteins.
3.3. Functional analysis of the truncated Q81X channels

Fig. 1. Analysis of the Q81X and P141fs+2X mutations using minigene constructs.
(A) Structure of the full-length hERG minigene construct. The positions of the wild-type termination codon (TER) and premature termination codons are indicated. (B) Analysis of
Q81X and P141fs+2X mRNA. HEK293 cells were transiently transfected with wild-type
(WT), Q81X, or P141fs+2X minigenes and the expressed mRNA was analyzed by the
RNase protection assay using a probe speciﬁc to 277 nt within exons 12 and 13 of hERG.
Cells expressing wild-type and mutant minigenes were treated (+) with 100 μg/ml cycloheximide (CHX) for 3 h prior to RNA isolation or left untreated (−). The level of
hygromycin resistance gene transcripts (Hygro) served as a loading control. (C) Normalized
signals were quantiﬁed and plotted as the mean percentage of wild-type±SEM (n=4).

Fig. 2. Western blot analysis of wild-type, Q81X, and P141fs+2X channels. (A) HEK293
cells were transiently transfected with wild-type, Q81X, and P141fs+2X hERG minigenes.
Proteins from whole cell lysates were subjected to SDS-PAGE and probed with anti-hERG
antibody. (B) HL-1 cardiomyocytes were transiently transfected with HA-tagged wildtype and Q81X constructs. Proteins were detected with anti-HA antibody. Mature, fully
glycosylated wild-type channels are 155 kDa; immature, core-glycosylated wild-type
channels are 135 kDa. Mature, fully-glycosylated Q81X channels are 140 kDa; immature,
core-glycosylated Q81X channels are 120 kDa. Untransfected cells, Unt. The results shown
are representative of three independent experiments.

To determine the functional properties of the Q81X channels we
performed whole cell patch clamp analysis of HEK293 cells transiently
transfected with either the wild-type or mutant minigenes. The
voltage-dependent activation of the channels was studied by recording
the tail current at −50 mV following a 4 s test potential to voltages
ranging between −70 and +60 mV. Representative current traces are
shown in Fig. 3A. The current density measured at the end of each activating potential is shown in Fig. 3B. The plots show that wild-type and
mutant channels both undergo voltage-dependent activation followed
by inactivation at more positive potentials. The averaged maximum
outward currents of wild-type (19.9 ± 4.1 pA/pF, n = 11) and Q81X
(18.3 ± 3.5 pA/pF, n =13), measured at +10 mV, were not signiﬁcantly different (P > 0.05, t-test). The peak tail current amplitudes, normalized to the maximum tail current amplitude, were ﬁt with a
Boltzmann function to generate activation curves for wild-type and
Q81X (Fig. 3C). The V1/2 and k values of Q81X channels, −12.1 ±
1.4 mV and 7.3 ± 0.5 (n=13), were not signiﬁcantly different from
those determined for wild-type channels, −13.2 ±2.3 mV and 8.0 ±
0.5 (n= 11, P >0.05, t-test). Q81X channels exhibited signiﬁcantly decreased tail current amplitudes relative to wild-type channels
(Fig. 3D). The average tail current densities, following test voltages of
+30 mV were 21.7± 3.4 pA/pF for wild-type (n= 11) and 11.8 ±
2.3 pA/pF (n= 13, P b 0.05, t-test) for Q81X channels, a 46% decrease.
Q81X channels also appeared to deactivate much more rapidly than
wild-type channels upon repolarization to −50 mV. Accelerated channel deactivation along with decreased surface density may underlie the
decreased tail current density of the mutant channels.
To further characterize the deactivation kinetics, channels were activated with a 1 s test potential to +60 mV and the deactivation tail currents were recorded upon repolarization to potentials ranging between
−40 and −120 mV. Representative current traces are shown in Fig. 4A.
The individual tail current traces were best ﬁt with a double exponential
function to determine the fast and slow time constants, τFast and τSlow,
of the deactivation rates. The voltage-dependencies of τFast and τSlow
are shown in Fig. 4B and C, respectively, and the kinetic properties of
the channels at −40 and −120 mV are summarized in Table 1. The
deactivation rates of Q81X channels were signiﬁcantly faster than
wild-type channels across all test potentials (wild-type, n = 6, Q81X,
n = 7, P b 0.05, ANOVA). At −40 mV the τFast and τSlow of the Q81X
channels were decreased by 78% and 84%, and at −120 mV by 74%
and 70%, respectively. Comparing the relative amplitudes associated
with τFast and τSlow time components revealed that the τFast makes a
greater contribution to the wild-type deactivation rate at more negative
potentials while it is the dominant component across all test potentials
in the Q81X channels (Fig. 4D). At −120 mV the τFast comprised 82%
and 87% of the total amplitude of the wild-type and Q81X deactivation
rates. At −40 mV the τFast of wild-type hERG comprised signiﬁcantly
less of the total amplitude of the deactivation rate compared with
Q81X channels, 29% versus 72%, respectively (P b 0.05, ANOVA). The increase in the deactivation rate is consistent with studies of N-terminally
truncated hERG channels [30,31].
We also characterized the voltage-dependence of inactivation using
a three-step protocol as previously described [26]. Brieﬂy, channels
were activated by a 0.5 s pulse to +40 mV, a second step to potentials
between −120 and +40 mV allowed the channels to recover from

Fig. 3. Electrophysiological properties of wild-type and Q81X channels. (A) Representative currents recorded from HEK293 cells transiently transfected with wild-type and Q81X
minigenes. hERG channels were activated with 4 s test potentials between −70 and +60 mV and tail current was recorded upon repolarization to −50 mV. (B) I–V plot of wildtype and Q81X current density measured at the end of the depolarizing pulse. (C) Activation curves determined using peak tail currents, normalized to maximum tail currents, and
ﬁt with a Boltzmann function (solid line). (D) I–V plot of peak tail current densities recorded at −50 mV, following depolarizing test potentials. Data were plotted as mean ± SEM,
wild-type (n = 11) and Q81X (n = 13).

inactivation, and the relative number of channels competent to activate
was determined by a third step to +40 mV. To minimize channel deactivation at negative test potentials we set the time of the hyperpolarizing pulse to 5 ms for Q81X and 20 ms for wild-type channels [27,32].
Representative current traces are shown in Fig. 5A and the kinetic properties are summarized in Table 1. The peak tail currents were plotted as
a function of voltage and ﬁt with a Boltzmann function (Fig. 5B). The
voltage at which 50% of the wild-type channels had recovered from inactivation was −57.6 ±1.7 mV (n= 7), which was not signiﬁcantly
different from the mutant channels −61.7± 3.0 mV (n= 5, P > 0.05,
t-test). We determined the time constants of the recovery from inactivation from the deactivation voltage clamp protocol shown in Fig. 4.
The time constants were determined by ﬁtting the initial 10 ms of the
rising phase of the deactivation voltage clamp protocol with a single exponential function. Due to the rapid rates of deactivation, the recovery
from inactivation could only be accurately determined at test potentials
positive to −60 mV [27]. We found that the mutant channels recovered
from inactivation signiﬁcantly faster than the wild-type channels across
all potentials. At −60 mV the time constant for recovery from inactivation was 6.4 ± 0.5 ms (n= 12) for wild-type and 2.8 ± 0.2 ms for the
Q81X mutant (n= 11, P b 0.05, ANOVA). A similar result was observed
in the recovery from inactivation of N-terminally truncated hERGb
channels compared with the full-length hERG channel [27].

premature termination. An analysis of the hERG coding sequence revealed three in-frame methionine codons downstream of the Q81X mutation, M124, M133, and M137, that could potentially serve as sites of
reinitiation (Fig. 6A). To determine whether translation was reinitiated
at these sites following termination at Q81X, we mutated the downstream methionine codons to valine codons in a Q81X cDNA construct
and analyzed hERG expression by western blot (Fig. 6B). When all
three methionine residues downstream of Q81X were mutated to valine the expression of the truncated channels was completely abolished.
This result indicates that downstream methionine codons at residue
124, 133, or 137 are required for reinitiation and supports the hypothesis that translation reinitiation allows the PTC-containing transcripts to
escape NMD. Truncated hERG channels were expressed when M133
and M137 were mutated to valine, indicating that M124 alone is able
to reinitiate translation. The expression of truncated channels from constructs containing Q81X and M124V mutations suggests that M133 or
M137 may contribute to translation reinitiation. These results support
the conclusion that the increased deactivation rates of the Q81X channels are the result of minimally deleting the ﬁrst 123 residues of the
hERG N-terminus. This is the ﬁrst report of a LQT2 mutation that generates N-terminally truncated hERG channels.

3.5. Q81X alters the inactivation and deactivation kinetics of heteromeric
channels
3.4. The Q81X mutation escapes NMD by the reinitiation of translation
The observation that Q81X channels exhibit increased rates of deactivation, together with the decreased molecular weight of the mutant
channel led to the hypothesis that translation is reinitiated following

Because the rates of channel deactivation and recovery from inactivation for the Q81X channels were signiﬁcantly faster than those of
wild-type channels, we determined whether the N-terminally truncated channels altered the functional properties of wild-type channels in

Fig. 4. Deactivation kinetics of wild-type and Q81X channels. (A) Representative currents recorded from HEK293 cells transiently transfected with wild-type and Q81X minigenes. hERG
channels were activated with a 1 s potential to +60 mV and the deactivation tail currents were recorded upon repolarization to potentials ranging between −40 and −120 mV. The tail
current was ﬁt with a double exponential function and the fast and slow components of the deactivation time constants of wild-type and Q81X channels are shown in (B) and (C). The time
constants for the fast and slow components of the deactivation rate were signiﬁcantly faster for Q81X channels at all test potentials (Pb 0.05, ANOVA). (D) Relative contribution of the fast
component of the deactivation time constants at −40 and −120 mV for wild-type and Q81X channels. All values were plotted as mean±SEM, wild-type (n=6) and Q81X (n=7).
*, Pb 0.05 compared to Q81X, ANOVA.

HEK293 cells co-transfected with equimolar amounts of wild-type and
Q81X minigenes. We used the deactivation voltage clamp protocol described in Fig. 4 to obtain the deactivation time constants as well as
the time constants for the rate of recovery from inactivation at test potentials positive to −60 mV. Representative deactivation current traces
are shown in Fig. 7A. Analysis of the deactivation kinetics indicated that
both the slow and fast components of the deactivation time constant
were intermediate between wild-type and Q81X channels (Fig. 7B,
Table 1) and were signiﬁcantly faster than wild-type rates at more positive test potentials. The τFast of heteromeric channels was signiﬁcantly
decreased compared with that of wild-type at test potentials positive to
−100 mV and the τSlow was signiﬁcantly decreased at test potentials

Table 1
Voltage-dependence of deactivation of wild-type hERG and Q81X.
Wild-type
Deactivation, at −40 mV
τFast (ms)
245.5 ± 23.0 (6)
1761.1 ± 100.5
τSlow (ms)
AFast / (AFast + ASlow)
0.29 ± 0.02
Deactivation, at −120 mV
38.7 ± 10.9
τFast (ms)
222.7 ± 55.4
τSlow (ms)
0.82 ± 0.07
AFast / (AFast + ASlow)
Inactivation
V1/2 (mV)
k (mV)
τRecovery at −60 mV
(ms)

−57.6 ± 1.7 (7)
−20.5 ± 0.3
6.4 ± 0.5 (12)

Q81X
54.2 ± 1.1a (7)
290.3 ± 25.3a
0.72 ± 0.03a

10.0 ± 1.1a
67.5 ± 7.8a
0.87 ± 0.03

−61.7 ± 3.0 (5)
−28.0 ± 0.9a
2.8 ± 0.2a (11)

Wild-Type + Q81X
141.4 ± 17.0a (6)
1233.9 ± 43.6a
0.51 ± 0.06a

31.0 ± 3.0
140.9 ± 10.0
0.81 ± 0.06

−57.3 ± 4.4 (5)
−22.8 ± 1.4
4.6 ± 0.5a (8)

Data were listed as mean± SEM. The numbers of cells are indicated in brackets.
a
Indicates a signiﬁcant difference compared to wild-type hERG (P b 0.05, ANOVA).

positive to −70 mV (P b 0.05, ANOVA). The time constants of the recovery from inactivation were also intermediate between wild-type and
mutant channels across all test potentials. At −60 mV the time constant for the recovery from inactivation was 4.6± 0.5, which was significantly faster than wild-type hERG (P b 0.05, ANOVA). These results
strongly suggest that wild-type and Q81X channels co-assemble to
generate heteromeric channels with altered kinetic properties.
To demonstrate the physical association between wild-type hERG
and Q81X we performed immunoprecipitation studies using differentially tagged wild-type and mutant hERG constructs. HEK293 cells stably expressing Flag-tagged wild-type channels were transiently transfected
with HA-tagged wild-type or Q81X cDNA constructs. The expression of
both wild-type and mutant channels was conﬁrmed by western blot
analysis using anti-HA and anti-Flag antibodies. Co-assembly of wildtype and mutant hERG channels was determined by immunoprecipitation with anti-Flag antibody followed by western blot analysis with
anti-HA antibody (Fig. 8). The membrane was also probed with antiFlag antibody demonstrating the efﬁciency of immunoprecipitation of
the Flag-tagged channels. The co-assembly between wild-type and
Q81X was observed in the immature and the mature forms of the
hERG protein indicating that heteromeric channels are able to undergo
complex glycosylation and trafﬁc to the cell-surface. These results indicate that the Q81X mutation alters the gating properties of heteromeric
hERG channels formed by co-assembly of wild-type and Q81X channels.

3.6. Q81X decreases resurgent outward current during ventricular action
potential clamp
LQT2 missense mutations which cause accelerated deactivation
rates have been shown to decrease the outward current through hERG
channels during the repolarization phase resulting in action potential

Fig. 5. Voltage-dependent inactivation of wild-type and Q81X channels. (A) Representative currents from HEK293 cells transiently transfected with wild-type and Q81X minigenes.
Current was recorded using a three-pulse protocol: channels were activated with a 0.5 s pulse to +40 mV followed by either a 20 ms or 5 ms hyperpolarizing pulse to potentials
between −120 and +40 mV, the inactivation currents were recorded following a ﬁnal pulse to +40 mV. (B) The corrected peak currents (described in the method), normalized to
maximum currents, were plotted versus voltage and ﬁt with a Boltzmann function. Values were plotted as mean ± SEM, wild-type (n = 7) and Q81X (n = 5).

prolongation [32]. To characterize the effect of the Q81X mutation during the ventricular action potential, we performed action potential
clamp using a waveform recorded from a human ventricular myocyte.
Fig. 9A shows the action potential waveform and the current traces
recorded from representative HEK293 cells transfected with wild-type,
Q81X, or both hERG constructs. Plotting the averaged current density
versus time (Fig. 9B) revealed no signiﬁcant difference in the current
levels during the plateau of the action potential. However, during the
late phases of the action potential, the mutant channels exhibited a signiﬁcant decrease in outward current levels compared to wild-type channels. We also plotted the averaged current density as a function of the
action potential voltage (Fig. 9C). Although the peak current densities
of Q81X and heteromeric channels were not signiﬁcantly decreased relative to wild-type hERG, both channels exhibited a signiﬁcant positive
shift in the peak potentials (Fig. 9D, Pb 0.05, ANOVA). The positive
shift in the peak potential of the mutant channels presumably results
from the rapid recovery from inactivation observed in these channels.

Fig. 6. Western blot analysis of translation reinitiation. (A) Schematic illustrating putative reinitiation sites downstream of the Q81X mutation. The partial cDNA sequence of
hERG exon 3 reveals three downstream methionine codons (underlined) which are
numbered according to the hERG cDNA sequence. (B) Western blot analysis of
HEK293 cells transiently transfected with wild-type and the Q81X, Q81X + M124V,
Q81X + M133V + M137V, and Q81X + M124V + M133V + M137V cDNA constructs.
Proteins were detected with anti-hERG antibody. The results shown are representative
of three independent experiments.

To determine the charge transferred during the action potential clamp,
we integrated the area under the current trace. The total charges transferred during the entire action potential were not signiﬁcantly different
among mutant and wild-type channels. However, the charges transferred during the late phase of the action potential, corresponding to
voltages more negative than −40 mV, were signiﬁcantly decreased in
Q81X and heteromeric channels compared to wild-type channels
(Fig. 9E, Pb 0.05, ANOVA). These results are consistent with previous
studies of hERG channels with LQT2 missense mutation in the N-terminal
domain [32].

Fig. 7. Dominant-negative effects of Q81X. (A) Representative current trace from
HEK293 cells transiently co-transfected with equimolar amounts of wild-type and
Q81X minigenes. hERG current was recorded using the protocols in the legend of
Fig. 4. (B) Voltage-dependence of the slow (circles) and fast (diamonds) components
of the deactivation time constants for the heteromeric wild-type + Q81X channels
are indicated as the black symbols (n = 6). The fast and slow components of deactivation of wild-type channels from Fig. 4 are shown as white symbols for comparison. The
time constants for the fast component of the deactivation rate were signiﬁcantly faster
for Q81X channels at test potentials positive to −100 mV and for the slow components
of the deactivation rate at test potentials positive to −70 mV (P b 0.05, ANOVA).

Fig. 8. Co-assembly of wild-type and Q81X channels. HA-tagged Q81X cDNA constructs
were transiently transfected into HEK293 cells stably expressing Flag-tagged wild-type
hERG channels. Cell lysates were subjected to immunoprecipitation using anti-Flag,
followed by western blot with anti-HA and anti-Flag antibody. HEK293 cells stably expressing Flag-tagged wild-type or transiently expressing HA-tagged Q81X were used as
controls. The lower two panels are inputs and are probed with anti-Flag and anti-HA
antibody. The results shown are representative of three independent experiments.

4. Discussion
In the present study, we describe a mechanism of long QT syndrome
in which hERG transcripts containing the Q81X nonsense mutation

escape NMD by the reinitiation of translation resulting in the generation
of N-terminally truncated channels. The full-length hERG minigenes
used in this study permitted a comprehensive analysis of this novel
mechanism at the mRNA, protein and functional levels. The resistance
to NMD and the subsequent translation of Q81X transcripts were
shown by the persistence of PTC-containing mRNA in the RNase protection assay, the detection of truncated channel proteins by western blot,
and the current recordings from the Q81X channels. The mutant channels exhibited decreased tail current density, accelerated deactivation
kinetics, reduced resurgent outward current and co-assembled with
wild-type hERG to form heteromeric channels with altered gating properties. The reinitiation of translation represents a new mechanism of
hERG channel dysfunction in LQT2.
The NMD surveillance mechanism has evolved to eliminate PTCs,
thereby, preventing the expression of potentially dangerous truncated
proteins. NMD is dependent on pre-mRNA splicing and the exonjunction protein complex (EJC) that is deposited 20–24 nt upstream of
each exon–exon junction. The EJC is normally displaced during the pioneer round of translation, but premature termination leaves the complex
intact which triggers NMD [33]. It has been proposed that PTCs occurring
b50 nt upstream of the last exon–exon junction or within the terminal
exon are immune to degradation by NMD [17]. Certain PTC mutations
occurring near the translational start site have also been shown to escape
NMD [34]. Translation may be reinitiated following premature termination when initiation factors are still associated with the ribosome,
allowing the ribosome to resume scanning for alternate start codons.
Generation of N-terminally truncated proteins by translation reinitiation
has been reported in a growing number of genes associated with
inherited diseases including the BRCA1, ATP7A and NEMO genes
[35–37]. Q81X represents the ﬁrst LQT2 mutation known to generate
N-terminally truncated hERG channels.
Translation reinitiation was conﬁrmed by the inhibition of protein
synthesis following the mutation of three methionine codons downstream of Q81X to valine. Our experimental results were consistent
with in silico analysis using the NetStart 1.0 server [38] which provides
a prediction of the likelihood of translation based on an artiﬁcial neural
network. Scores generated by NetStart 1.0 range between 0.0 and 1.0
and a score greater than 0.5 represents a probable start site. M124
was scored at 0.85 indicating a strong likelihood of translation initiation
(for comparison the hERG M1 was scored at 0.64). The downstream

Fig. 9. hERG current during ventricular action potential clamp. (A) The ventricular action potential clamp waveform (upper trace) used to generate the representative current traces of
wild-type hERG, Q81X and wild-type+Q81X channels (lower traces). (B) Plot of the averaged current density versus time during the ventricular action potential clamp. (C) Plot of the
averaged current density as a function of action potential voltage. (D) Peak current density plotted as a function of peak potential. (E) Plot of the charge density transferred during the late
phases of repolarization of the ventricular action potential clamp at potentials negative to −40 mV. Data were plotted as mean±SEM, wild-type (n=6), Q81X (n=4), wild-type+Q81X
(n=5), *, Pb 0.05 compared to wild-type hERG, ANOVA.

M133 and M137 codons received lower scores, 0.42 and 0.47, respectively. Following M137, the next in-frame start codon is M218, and although its predicted score is 0.75, it is unable to reinitiate translation
of transcripts containing the Q81X or the P141fs+2X mutations. Three
lines of evidence lead to the conclusion that M124 is a preferred site
of translation reinitiation in the Q81X mutant. First, M124 is the ﬁrst
in-frame methionine codon following the Q81X mutation, second, the
in silico analysis predicts a very high translation initiation score, and
third, the results of our mutagenesis study indicating that M124 alone
can be used to synthesize truncated channels.
The N-terminus of hERG contains several regions that contribute to
the maintenance of slow channel deactivation. These regions include
an initial unordered segment comprised of residues 2–9, an amphiphatic
α-helix formed by residues 13–23 and a helix-loop-helix motif Per, Arnt
and Sim (PAS) domain that encompasses residues 26–135 [39–41]. The
importance of these regions was determined by functional studies showing that N-terminally truncated hERG channels exhibited increased rates
of deactivation relative to the full-length channel [30,31,39,42]. Early
studies suggested that deactivation was regulated by interactions between the N-terminus and the S4–S5 linker [39,43,44]. Recent studies
have provided strong evidence that deactivation is regulated by interactions between N-terminus and the cytosolic C-terminus of the channel.
FRET studies revealed that a PAS domain fragment interacted with the
cytoplasmic C-terminus of hERG and was sufﬁcient to restore the regulation of deactivation of LQT2 mutant channels [45]. Muskett et al. recently
reported an acidic patch on the cyclic nucleotide-binding homology
domain as a putative interface for the binding of the N-terminus [40].
Several LQT2 missense mutations within the hERG N-terminus exhibit
similar accelerated deactivation properties to N-terminally truncated
channels [28,32]. The deletion of these N-terminal domains in Q81X
channels explains the observed increase in deactivation rates.
The mutant channel generated less outward current during the late
phases of repolarization in ventricular action potential clamp studies.
Two factors may contribute to the loss of repolarizing current: increased
rates of deactivation and decreased numbers of channels expressed at
the cell surface. Decreased surface density of hERG may arise from reduced efﬁciencies of translation reinitiation or by trafﬁcking deﬁciencies of the N-terminally truncated channels. Future studies will be
necessary to determine the relative contribution of these factors to the
loss of repolarizing current and to elucidate the precise mechanism of
cardiac action potential prolongation. The Q81X channels also exhibited
a signiﬁcant positive shift in the peak potential during the action potential clamp indicating that the mutant channels peak earlier during the
action potential. This shift may arise from the increased rates of recovery from inactivation in the mutant channels. The earlier peak of the
mutant channel did not result in a signiﬁcant change in the total charge
transferred during the action potential. Rather, we observed a signiﬁcant decrease in the charge transferred during the late phases of action
potential repolarization caused by a decrease in the outward current.
The present results suggest that generation of smaller outward current
and transfer of less charge during the repolarization phase of the cardiac
action potential contribute to the prolongation of the QT interval in
affected individuals.
Previous studies have identiﬁed several pathogenic mechanisms of
LQT2 mutations. These mechanisms include defective trafﬁcking and
assembly, abnormal gating or kinetics, the disruption of channel permeability, and degradation of PTC-containing transcripts by NMD. The
reinitiation of translation by LQT2 nonsense mutations represents a
novel mechanism to generate dysfunctional hERG channels. Identiﬁcation of reinitiation of translation by nonsense mutations may have important implications for the clinical phenotype in LQT2. For example,
NMD is often associated with a mild clinical phenotype arising from
haploinsufﬁciency and it is likely that the translation reinitiation mechanism that allows LQT2 mutations to escape this surveillance pathway
and generate N-terminally truncated hERG channels may give rise to
more severe pathogenic phenotypes.

In summary, our ﬁnding that the LQT2 nonsense mutation Q81X escapes NMD by the reinitiation of translation has increased our understanding of mechanisms that cause long QT syndrome. Translation
reinitiation may represent a new pathogenic role of early LQT2
nonsense and frameshift mutations in the hERG gene. Furthermore,
the characterization of a naturally occurring mutation that generates
N-terminally truncated hERG channels provides biological signiﬁcance
for studies of the structure and function of the hERG N-terminus.
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